DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of MK8245 (8245–004)(COMPLETED).
Accessed June 15, 2021 at:
https://ClinicalTrials.gov/show/NCT00790556
We do not assume any responsibility for the contents of the web pages of other providers.